Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018223180) RADIOPHARMACEUTICALS, RADIOIMAGING AGENTS, AND USES THEREOF
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/223180 International Application No.: PCT/AU2018/050555
Publication Date: 13.12.2018 International Filing Date: 05.06.2018
IPC:
C07D 487/08 (2006.01) ,C07F 1/08 (2006.01) ,A61K 33/34 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
487
Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/-C07D477/183
02
in which the condensed system contains two hetero rings
08
Bridged systems
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
F
ACYCLIC, CARBOCYCLIC, OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
1
Compounds containing elements of the 1st Group of the Periodic System
08
Copper compounds
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33
Medicinal preparations containing inorganic active ingredients
24
Heavy metals; Compounds thereof
34
Copper; Compounds thereof
Applicants:
THE UNIVERSITY OF MELBOURNE [AU/AU]; Melbourne, Victoria 3010, AU
Inventors:
ZIA, Nicholas Alan; AU
DONNELLY, Paul Stephen; AU
Agent:
DAVIES COLLISON CAVE PTY LTD; Level 15, 1 Nicholson Street Melbourne, Victoria 3000, AU
Priority Data:
201790215106.06.2017AU
Title (EN) RADIOPHARMACEUTICALS, RADIOIMAGING AGENTS, AND USES THEREOF
(FR) AGENTS RADIOPHARMACEUTIQUES, AGENTS DE RADIOIMAGERIE ET UTILISATIONS ASSOCIÉES
Abstract:
(EN) The present invention relates to compounds that are useful as radiopharmaceuticals and radioimaging agents which bear a radionuclide-chelating agent. These coordinated compounds are useful in radiotherapy and diagnostic imaging. The invention also relates to methods of diagnosis, prognosis and therapy utilising the non-coordinated and radiolabelled compounds of the invention.
(FR) La présente invention concerne des composés qui sont utiles en tant qu'agents radiopharmaceutiques et en tant qu'agents de radioimagerie portant un agent chélatant de radionucléides. Ces composés coordonnés sont utiles dans l'imagerie de radiothérapie et de diagnostic. L'invention concerne également des procédés de diagnostic, de pronostic et de traitement utilisant les composés non-coordonnés et radiomarqués selon l'invention.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)